These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1955 related articles for article (PubMed ID: 8386711)
1. In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5. Rivoltini L; Viggiano V; Spinazzè S; Santoro A; Colombo MP; Takatsu K; Parmiani G Int J Cancer; 1993 Apr; 54(1):8-15. PubMed ID: 8386711 [TBL] [Abstract][Full Text] [Related]
2. Mast cells enhance eosinophil survival in vitro: role of TNF-alpha and granulocyte-macrophage colony-stimulating factor. Levi-Schaffer F; Temkin V; Malamud V; Feld S; Zilberman Y J Immunol; 1998 Jun; 160(11):5554-62. PubMed ID: 9605160 [TBL] [Abstract][Full Text] [Related]
3. Eosinophil colony-stimulating factor induced by administration of interleukin-2 into the pleural cavity of patients with malignant pleurisy. Nakamura Y; Ozaki T; Yanagawa H; Yasuoka S; Ogura T Am J Respir Cell Mol Biol; 1990 Oct; 3(4):291-300. PubMed ID: 2206537 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression. Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS J Immunol; 2003 Jun; 170(11):5359-66. PubMed ID: 12759409 [TBL] [Abstract][Full Text] [Related]
5. The effect of transendothelial migration on eosinophil function. Yamamoto H; Sedgwick JB; Vrtis RF; Busse WW Am J Respir Cell Mol Biol; 2000 Sep; 23(3):379-88. PubMed ID: 10970830 [TBL] [Abstract][Full Text] [Related]
6. Granulocyte-macrophage colony-stimulating factor induces sequential activation and deactivation of binding via a low-affinity IgG Fc receptor, hFc gamma RII, on human eosinophils. Koenderman L; Hermans SW; Capel PJ; van de Winkel JG Blood; 1993 May; 81(9):2413-9. PubMed ID: 8481520 [TBL] [Abstract][Full Text] [Related]
8. [Induction of gene (mRNA) expression of CD23, CD25 and CD4 on eosinophils by eosinophilopoietic growth lymphokines]. Chihara J; Nakajima S Nihon Rinsho; 1993 Mar; 51(3):581-7. PubMed ID: 8492430 [TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha is necessary for granulocyte-macrophage-colony-stimulating-factor-induced eosinophil transendothelial migration. Erger RA; Casale TB Int Arch Allergy Immunol; 1998 Jan; 115(1):24-32. PubMed ID: 9430492 [TBL] [Abstract][Full Text] [Related]
10. Induction of CD23, CD25 and CD4 expression on an eosinophilic cell line (EoL-3) by interleukin-3 (IL-3), granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-5 (IL-5). Chihara J; Gruart V; Plumas J; Tavernier J; Kusnierz JP; Prin L; Capron A; Capron M Eur Cytokine Netw; 1992; 3(1):53-61. PubMed ID: 1533800 [TBL] [Abstract][Full Text] [Related]
11. Transfer of the interleukin-2 gene into human cancer cells induces specific antitumor recognition and restores the expression of CD3/T-cell receptor associated signal transduction molecules. Guarini A; Riera L; Cignetti A; Montacchini L; Massaia M; Foa R Blood; 1997 Jan; 89(1):212-8. PubMed ID: 8978294 [TBL] [Abstract][Full Text] [Related]
12. Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders. Heinisch IV; Bizer C; Volgger W; Simon HU J Allergy Clin Immunol; 2001 Jul; 108(1):21-8. PubMed ID: 11447378 [TBL] [Abstract][Full Text] [Related]
13. Eosinophils activation in post-autologous bone marrow transplanted patients treated with subcutaneous interleukin-2 and interferon-alpha 2A immunotherapy. Fabian I; Kravtsov V; Elis A; Gurevitch O; Ackerstein A; Slavin S; Nagler A Leukemia; 1994 Aug; 8(8):1379-84. PubMed ID: 8057677 [TBL] [Abstract][Full Text] [Related]
14. Effects of IL-5, granulocyte/macrophage colony-stimulating factor (GM-CSF) and IL-3 on the survival of human blood eosinophils in vitro. Tai PC; Sun L; Spry CJ Clin Exp Immunol; 1991 Aug; 85(2):312-6. PubMed ID: 1864012 [TBL] [Abstract][Full Text] [Related]
15. Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy. Corrigan CJ; Hamid Q; North J; Barkans J; Moqbel R; Durham S; Gemou-Engesaeth V; Kay AB Am J Respir Cell Mol Biol; 1995 May; 12(5):567-78. PubMed ID: 7742019 [TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma enhances human eosinophil effector functions induced by granulocyte-macrophage colony-stimulating factor or interleukin-5. Yamaguchi T; Kimura H; Kurabayashi M; Kozawa K; Kato M Immunol Lett; 2008 Jun; 118(1):88-95. PubMed ID: 18440651 [TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects of IL-3, granulocyte-macrophage colony-stimulating factor, and macrophage colony-stimulating factor in supporting monocyte differentiation in culture. Analysis of macrophage antibody-dependent cellular cytotoxicity. Young DA; Lowe LD; Clark SC J Immunol; 1990 Jul; 145(2):607-15. PubMed ID: 2142182 [TBL] [Abstract][Full Text] [Related]